We believe DexCom stock (NASDAQ: DXCM) is currently a better pick than Abbott stock (NYSE: ABT), given its better prospects. Although Abbott is trading at a comparatively lower valuation of 3.8x ...
Medical device maker Medtronic has teamed up with Fitbit to integrate physical activity data with blood glucose levels into one streamlined application. People living with type 2 diabetes who use ...
Manage diabetes and not CGM interruptions with the new Eversense 365 CGM system – the only One Year CGM that is designed to help minimize device frustrations Ascensia launches the world’s first One ...
Abbott has initiated a medical device correction for certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors ...
In what is undoubtedly a historic win for diabetes management, FDA has cleared the first over-the-counter (OTC) glucose biosensor. Indicated for adults (18 years and up) who are not using insulin ...
Watching blood sugar levels is essential for people with diabetes, and it’s becoming a trendy option among non-diabetics as well. A growing number of people are using continuous glucose monitoring ...
This diabetes technology offers a continuous stream of data to show a more complete picture of your blood sugars over time. This is different from a fingerstick meter that only represents that moment.
Please provide your email address to receive an email when new articles are posted on . McKee and colleagues conducted a retrospective survey of adults attending the Washington ...
DexCom is a major player in the continuous glucose monitoring space, with steadily growing revenues and a breakout year in 2020. DXCM's market cap valuation has reached $40 billion, leading to high ...
Dublin, Nov. 11, 2025 (GLOBE NEWSWIRE) -- The "Insulin Storage Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
Continuous glucose monitors (CGMs) may help curb the severity of hypoglycemia after weight-loss operations and even other gastrointestinal procedures, according to recent findings from a small study ...